Services
Show submenu for Services
Biological samples
Show submenu for Biological samples
Cancer
Rare diseases
COVID-19
Other diseases
Healthy donors
COVID-19
Show submenu for COVID-19
Drug testing
Diagnostics tests
Vaccine development
R&D Services
Show submenu for R&D Services
Analytical methods
Bioprocess
Cell & tissue imaging
Chemistry & Biochemistry
In vitro, Ex vivo & Cells
In vivo & ADME
Informatics
Genomics & Transcriptomics
Proteomics
Microbiology
About us
Blog
Services
Show submenu for Services
Biological samples
Show submenu for Biological samples
Cancer
Rare diseases
COVID-19
Other diseases
Healthy donors
COVID-19
Show submenu for COVID-19
Drug testing
Diagnostics tests
Vaccine development
R&D Services
Show submenu for R&D Services
Analytical methods
Bioprocess
Cell & tissue imaging
Chemistry & Biochemistry
In vitro, Ex vivo & Cells
In vivo & ADME
Informatics
Genomics & Transcriptomics
Proteomics
Microbiology
About us
Blog
English
Français
en
Contact Us
Regulatory preclinical studies for COVID-19 drug development
Service description
All regulatory tests necessary for COVID-19 preclinical drug development dossier:
toxicity, carcinogenicity, in vitro and in vivo in small animals.
This service is designed for
Biotech companies developing SARS-CoV-2 new drugs
.
Materials to provide
Details about the request
.
A
specific regulatory process
may be required for project approval.
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
Typical deliverables
Study following the specifications validated with the Expert.
Get started with your COVID-19 preclinical in vivo and
in vitro
tests
Please answer the fields below to be contacted by our team of scientists
COVID-19 Services
Biological Samples
Experimental Services
You could not find what you are looking for? Search for your service here: